Case studies have highlighted the importance of synovial macrophages as a predictor of response to anti-TNF in RA [41,153], whilst a recent study reported that response to Tocilizumab (IL-6 inhibitor) is associated with the presence of myeloid cells in synovial B cell-poor subjects [154]. This evidence concerns the gene TNF and rheumatoid arthritis.